Key regions: Australia, Europe, South Africa, United States, Netherlands
Amidst the picturesque landscapes and vibrant cultures of Southern Europe, the Medical Cannabis market is experiencing notable growth and evolution.
Customer preferences: Customers in Southern Europe are increasingly turning to Medical Cannabis for its potential health benefits and therapeutic properties. The shift towards natural remedies and alternative medicine is driving demand for Medical Cannabis products across the region. Patients are seeking relief from various medical conditions and are drawn to the growing availability of Medical Cannabis as a treatment option.
Trends in the market: In Spain, there is a rising trend towards the legalization and regulation of Medical Cannabis, with a growing number of regions allowing its use for medical purposes. This trend is fueled by a changing perception of cannabis as more research highlights its potential medical benefits. Italy is also seeing advancements in the Medical Cannabis market, with the government taking steps to expand access to medical marijuana products for patients in need. Furthermore, Portugal has emerged as a key player in the cultivation and export of Medical Cannabis within the region, capitalizing on its favorable climate for cultivation.
Local special circumstances: Southern European countries like Greece and Malta are strategically positioning themselves to become key players in the Medical Cannabis market. Greece, with its favorable climate and supportive regulatory framework, is attracting investments in cannabis cultivation and production. Malta, on the other hand, is leveraging its strategic location and EU membership to establish itself as a hub for Medical Cannabis trade within the region. These local special circumstances are contributing to the growth and development of the Medical Cannabis market in Southern Europe.
Underlying macroeconomic factors: The evolving regulatory landscape and increasing acceptance of Medical Cannabis for medical use are key macroeconomic factors driving the growth of the market in Southern Europe. As governments across the region recognize the potential economic benefits of a regulated Medical Cannabis market, they are taking steps to facilitate its growth. Additionally, the growing trend towards cannabis legalization globally is creating opportunities for Southern European countries to tap into the expanding international market for Medical Cannabis products.
Data coverage:
Data encompasses B2B and B2C enterprises. Figures are based on companies' revenues, funding values and global consumer survey data. Revenues include retail, sales and taxes.Modeling approach / Market size:
Market sizes are determined by a Top-Down approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports, third-party data. Next, we use relevant key market indicators and data from country-specific associations such as tobacco spending per capita, medical product spending per capita, consumer spending and consumer spending for recreation purposes, population. This data helps us to estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function.Additional Notes:
The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
